Attorneys for Starbucks Corp. and other coffee sellers have less than two weeks to persuade a Los Angeles County judge to reconsider a proposed ruling that could force them to post cancer warnings in stores and on packages.

Superior Court Judge Elihu Berle, in a tentative decision issued Wednesday after a trial, said Starbucks and dozens of other defendants had failed to prove that the level of acrylamide in their coffee poses no significant health risk.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]